Where are mutual funds investing your money? These stocks saw the biggest buying in September 2026. Check full list

Among mid-cap companies, Swiggy attracted the highest buying, with mutual funds purchasing shares worth ₹3,241 crore during September. (AI-generated image used for representational purpose.)AI Quick ReadIndian mutual funds invested heavily in select large-, mid- and small-cap stocks in September 2026, with Reliance Industries, Swiggy and Gland Pharma emerging as the biggest purchases in their respective categories.

An analysis by Value Research, based on the August and September 2026 portfolio disclosures of actively managed mutual funds, reveals where fund managers increased their investments during the month.

Banking, financial services, pharmaceuticals and technology-related businesses featured prominently among the stocks attracting significant buying.

Reliance Industries emerged as the most purchased large-cap stock in September, with mutual funds buying shares worth ₹4,605 crore. The total value of their holdings in the company stood at ₹99,267 crore at the end of the month.

NSE secured the second position, attracting purchases worth ₹3,171 crore, followed closely by HDFC Bank, where mutual funds bought shares worth ₹3,142 crore.

ICICI Bank was another major beneficiary, recording purchases worth ₹2,689 crore. Despite ranking fourth in fresh purchases, it had the highest total mutual fund holdings among these five stocks at ₹1,96,008 crore.

Bajaj Finance completed the top five, with purchases worth ₹1,986 crore.

Among mid-cap companies, Swiggy attracted the highest buying, with mutual funds purchasing shares worth ₹3,241 crore during September.

The total value of mutual fund holdings in the food delivery company stood at ₹19,503 crore at the end of the month.

PB Fintech, the parent company of Policybazaar, ranked second with purchases worth ₹1,472 crore, followed by Lenskart Solutions at ₹1,256 crore.

Multi Commodity Exchange of India (MCX) attracted investments worth ₹1,101 crore, while Zydus Lifesciences completed the top five with purchases worth ₹1,021 crore.

The presence of Swiggy, PB Fintech and Lenskart among the biggest purchases indicates that digital consumer businesses attracted substantial mutual fund buying during September.

Gland Pharma emerged as the most purchased small-cap stock in September, with mutual funds buying shares worth ₹1,849 crore.

The total value of mutual fund holdings in the pharmaceutical company reached ₹13,719 crore.

Aditya Infotech ranked second, attracting purchases worth ₹1,212 crore, followed by Pearl Global Industries at ₹1,113 crore.